Dr. Crowhurst has extensive experience before the European Patent Office (EPO), handling prosecution, oppositions, responses, and global portfolio management for clients across a wide range of scientific and engineering sectors. She advises on IP strategies throughout the R&D continuum — from early-stage innovation and preclinical development to product commercialization — integrating scientific insight with rigorous legal analysis to support licensing, risk assessment, and competitive-patent evaluation.
With substantial experience representing clients from Asia, including Japan, Taiwan, and Korea, Dr. Crowhurst is well attuned to the procedural, cultural, and technical differences between Asian and European IP systems. Her ability to craft European and global patent strategies aligned with scientific, regulatory, and market demands makes her a highly valued partner for companies seeking to commercialize advanced technologies across multiple jurisdictions.
